Linthorst G - Search Results

1

The potential role of thrombopoietin in idiopathic thrombocytopenic purpura.

von dem Borne A, Folman C, van den Oudenrijn S, Linthorst G, de Jong S, de Haas M. von dem Borne A, et al. Among authors: linthorst g. Blood Rev. 2002 Mar;16(1):57-9. doi: 10.1054/blre.2001.0184. Blood Rev. 2002. PMID: 11913997 Review.

2

Thrombopoietin and its receptor: structure, function and role in the regulation of platelet production.

von dem Borne AE, Folman C, Linthorst GE, Porcelijn L, van den Oudenrijn S, van der Schoot E, de Haas M. von dem Borne AE, et al. Among authors: linthorst ge. Baillieres Clin Haematol. 1998 Jun;11(2):409-26. doi: 10.1016/s0950-3536(98)80058-9. Baillieres Clin Haematol. 1998. PMID: 10097817 Review. No abstract available.

3

Thrombopoietin: its role in platelet disorders and as a new drug in clinical medicine.

von dem Borne AE, Folman C, Linthorst GE, Porcelijn L, van den Oudenrijn S, van der Schoot E, de Haas M. von dem Borne AE, et al. Among authors: linthorst ge. Baillieres Clin Haematol. 1998 Jun;11(2):427-45. doi: 10.1016/s0950-3536(98)80059-0. Baillieres Clin Haematol. 1998. PMID: 10097818 Review. No abstract available.

4

Serum levels of thrombopoietin, IL-11, and IL-6 in pediatric thrombocytopenias.

Cremer M, Schulze H, Linthorst G, Folman CC, Wehnert S, Strauss G, von dem Borne AE, Welte K, Ballmaier M. Cremer M, et al. Among authors: linthorst g. Ann Hematol. 1999 Sep;78(9):401-7. doi: 10.1007/s002770050538. Ann Hematol. 1999. PMID: 10525827

5

Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis?

Folman CC, Linthorst GE, van Mourik J, van Willigen G, de Jonge E, Levi M, de Haas M, von dem Borne AE. Folman CC, et al. Among authors: linthorst ge. Thromb Haemost. 2000 Jun;83(6):923-30. Thromb Haemost. 2000. PMID: 10896250

6

Plasma thrombopoietin levels in patients with chronic renal failure.

Linthorst GE, Folman CC, van Olden RW, von dem Borne AE. Linthorst GE, et al. Hematol J. 2002;3(1):38-42. doi: 10.1038/sj.thj.6200153. Hematol J. 2002. PMID: 11960394

7

Blood group does not correlate with disease severity in patients with Fabry disease (alpha-galactosidase A deficiency).

Linthorst GE, Folman CC, Aerts JM, Hollak CE. Linthorst GE, et al. Blood Cells Mol Dis. 2003 Nov-Dec;31(3):324-6. doi: 10.1016/s1079-9796(03)00163-3. Blood Cells Mol Dis. 2003. PMID: 14636646

8

Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase alpha and beta.

Linthorst GE, Hollak CE, Donker-Koopman WE, Strijland A, Aerts JM. Linthorst GE, et al. Kidney Int. 2004 Oct;66(4):1589-95. doi: 10.1111/j.1523-1755.2004.00924.x. Kidney Int. 2004. PMID: 15458455 Free article. Clinical Trial.

9

Rhabdomyolysis: review of the literature.

Zutt R, van der Kooi AJ, Linthorst GE, Wanders RJ, de Visser M. Zutt R, et al. Among authors: linthorst ge. Neuromuscul Disord. 2014 Aug;24(8):651-9. doi: 10.1016/j.nmd.2014.05.005. Epub 2014 May 21. Neuromuscul Disord. 2014. PMID: 24946698 Review.

10

Acid sphingomyelinase (Asm) deficiency patients in The Netherlands and Belgium: disease spectrum and natural course in attenuated patients.

Hollak CE, de Sonnaville ES, Cassiman D, Linthorst GE, Groener JE, Morava E, Wevers RA, Mannens M, Aerts JM, Meersseman W, Akkerman E, Niezen-Koning KE, Mulder MF, Visser G, Wijburg FA, Lefeber D, Poorthuis BJ. Hollak CE, et al. Among authors: linthorst ge. Mol Genet Metab. 2012 Nov;107(3):526-33. doi: 10.1016/j.ymgme.2012.06.015. Epub 2012 Jun 30. Mol Genet Metab. 2012. PMID: 22818240

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

120 results

Search Page